Protein biomarker discovery and validation: the long and uncertain path to clinical utility

STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT

Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011

Akufo and Ibarapa

Beckett, A. H., Rowland, M., & TURNER, P. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,917

Practical Statistics for Medical Research.

Walter, S., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,666

Mass spectrometry-based proteomics

Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955

Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine

ZWEIG, M. H., & Campbell, G. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.4.561 · Cited by 6,595

Practical Statistics for Medical Research.

Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,834

The Human Plasma Proteome

Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101

Systems for Multiplexing Homogeneous Immunoassays

Yamanishi, C. D., Chiu, J. H.-C., & Takayama, S. (2015) · Bioanalysis · doi:10.4155/bio.15.78 · Cited by 19

Degradomics in Biomarker Discovery

Grozdanić, M., Vidmar, R., Vizovišek, M., & Fonovič, M. (2019) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800138 · Cited by 19

Label-free detection of biomarker alpha fetoprotein in serum by ssDNA aptamer functionalized magnetic nanoparticles

Su, Y., Xue, T., Wu, L., Hu, Y., Wang, J., Xu, Q., Chen, Y., & Lin, Z. (2019) · Nanotechnology · doi:10.1088/1361-6528/ab57f7 · Cited by 19

Identification and verification of three key genes associated with survival and prognosis of COAD patients via integrated bioinformatics analysis

Liu, Y., Li, C., Dong, L., Li, P., 陈, 学., & Fan, R. (2020) · Bioscience Reports · doi:10.1042/bsr20200141 · Cited by 19

Proteomic detection of nitroproteins as potential biomarkers for cardiovascular disease

Aslan, M., & Doğan, S. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.029 · Cited by 19

Emergence of pathway-level composite biomarkers from converging gene set signals of heterogeneous transcriptomic responses

Zaim, S. R., Li, Q., Schissler, A. G., & Lussier, Y. A. (2017) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789813235533_0044 · Cited by 19

Critical Reagent Screening and Characterization: Benefits and Approaches for Protein Biomarker Assays by Hybrid LC–MS

Santockyte, R., Zeng, J., & Zheng, N. (2019) · Bioanalysis · doi:10.4155/bio-2018-0277 · Cited by 19

Biomarkers in translational research: focus on discovery, development and translation of protein biomarkers to clinical immunoassays

Rai, A. J. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.5.545 · Cited by 19

Proteomics techniques in protein biomarker discovery

Babaei, M., Kashanian, S., Lee, H., & Harding, F. J. (2024) · Quantitative Biology · doi:10.1002/qub2.35 · Cited by 18

Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate Vasculitis

Porritt, R. A., Huizar, C. C., Dick, E. J., Kumar, S., Escalona, R., Gomez, A. C., Marek‐Iannucci, S., Rivas, M. N., Patterson, J., Forsthuber, T. G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630196 · Cited by 18

Genomic and proteomic biomarker landscape in clinical trials

Piñero, J., Fraga, P. S. R., Valls-Margarit, J., Ronzano, F., Accuosto, P., Jane, R. L., Sanz, F., & Furlong, L. I. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.03.014 · Cited by 19

Engineering sampling microneedles for biomolecules sensing

Cheng, Y., Luan, X., Weng, J., Zhang, L., & Ye, F. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.156130 · Cited by 18

Quantitative analysis of low-abundance serological proteins with peptide affinity-based enrichment and pseudo-multiple reaction monitoring by hybrid quadrupole time-of-flight mass spectrometry

Kim, K. H., Ahn, Y. H., Ji, E. S., Lee, J. Y., Kim, J. Y., An, H. J., & Yoo, J. S. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2015.04.033 · Cited by 18

A practical guide to epidemiological practice and standards in the identification and validation of diagnostic markers using a bladder cancer example

Behrens, T., Bonberg, N., Casjens, S., Pesch, B., & Brüning, T. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.07.018 · Cited by 18

Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis

Dagley, L. F., Emili, A., & Purcell, A. W. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200104 · Cited by 19

A highly multiplexed quantitative phosphosite assay for biology and preclinical studies

Keshishian, H., McDonald, E. R., Mundt, F., Melanson, R., Krug, K., PORTER, D. A., Wallace, L., Forestier, D., Rabasha, B., Marlow, S., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010156 · Cited by 17

Plasma protein analysis of patients with different B ‐cell lymphomas using high‐content antibody microarrays

Schröder, C., Srinivasan, H., Sill, M., Linseisen, J., Fellenberg, K., Becker, N., Nieters, A., & Hoheisel, J. D. (2013) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300048 · Cited by 18

Important Issues in Planning a Proteomics Experiment: Statistical Considerations of Quantitative Proteomic Data

Podwojski, K., Stephan, C., & Eisenacher, M. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-885-6_1 · Cited by 18

Serological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease

Yau, Y. Y., Leong, R. W. L., Pudipeddi, A. V., Redmond, D., & Wasinger, V. C. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.066506 · Cited by 18

Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation

Bhosale, S. D., Moulder, R., Kouvonen, P., Lahesmaa, R., & Goodlett, D. R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7057-5_31 · Cited by 19

Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta‐analysis

Mi, Y., Zhao, Y., Shi, F., Zhang, M., Wang, C., & Liu, X. (2018) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13024 · Cited by 18

Sepsis Biomarkers

Wong, H. R. (2019) · Journal of Pediatric Intensive Care · doi:10.1055/s-0038-1677537 · Cited by 19

Profiling of endogenous peptides by multidimensional liquid chromatography: On‐line automated sample cleanup for biomarker discovery in human urine

Machtejevas, E., Marko‐Varga, G., Lindberg, C., Lubda, D., Hendriks, R., & Unger, K. K. (2009) · Journal of Separation Science · doi:10.1002/jssc.200900058 · Cited by 18

Understanding the Role of Immunoaffinity-Based Mass Spectrometry Methods for Clinical Applications

Ackermann, B. L. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.193714 · Cited by 18

Whole proteomes as internal standards in quantitative proteomics

Ong, S. (2010) · Genome Medicine · doi:10.1186/gm170 · Cited by 18

Anti-Rheumatic potential of biological DMARDS and protagonistic role of bio-markers in early detection and management of rheumatoid arthritis

Riaz, M., Rasool, G., Yousaf, R., Fatima, H., Munir, N., & Ejaz, H. (2025) · Innate Immunity · doi:10.1177/17534259251324820 · Cited by 22

New Technologies for Monitoring Marine Mammal Health

Mancia, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812144-3.00011-5 · Cited by 21

Proteomics Landscape of Alzheimer’s Disease

Jain, A., & Sathe, G. J. (2021) · Proteomes · doi:10.3390/proteomes9010013 · Cited by 18

Targeted proteomics for cancer biomarker verification and validation

Ogata, S., Masuda, T., Ito, S., & Ohtsuki, S. (2022) · Cancer Biomarkers · doi:10.3233/cbm-210218 · Cited by 17

Osteoimmunomodulation role of exosomes derived from immune cells on osseointegration

Xiao, Y., Ding, Y., Zhuang, J., Sun, R., Sun, H., & Bai, L. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.989537 · Cited by 18

Defining Biological Remission in Crohn’s Disease: Interest, Challenges and Future Directions

Pierre, N., Vieujean, S., Peyrin‐Biroulet, L., Meuwis, M., & Louis, E. J. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad086 · Cited by 17

Micro-volume wall-less immunoassays using patterned planar plates

Kozak, K. R., Wang, J., Lye, M., Chuh, J., Takkar, R., Kim, N. Y., Lee, H., Jeon, N. L., Lin, K., Zhang, C., et al. (2013) · Lab on a Chip · doi:10.1039/c3lc40973b · Cited by 17

Getting Started in Computational Mass Spectrometry–Based Proteomics

Olga Vitek, A. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000366 · Cited by 17

Biochips that sequentially capture and focus antigens for immunoaffinity MALDI‐TOF MS: A new tool for biomarker verification

Brauer, H. A., Lampe, P. D., Yasui, Y., Hamajima, N., & Stolowitz, M. L. (2010) · PROTEOMICS · doi:10.1002/pmic.201000219 · Cited by 17

Quantitative Proteomics Using The High Resolution Accurate Mass Capabilities of The Quadrupole-Orbitrap Mass Spectrometer

Gallien, S., & Domon, B. (2014) · Bioanalysis · doi:10.4155/bio.14.115 · Cited by 17

MRM assay for quantitation of complement components in human blood plasma — a feasibility study on multiple sclerosis

Rezeli, M., Végvári, Á., Ottervald, J., Olsson, T. P., Laurell, T., & Marko‐Varga, G. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.042 · Cited by 17

Protein sensing and discrimination using highly functionalised ruthenium( ii ) tris(bipyridyl) protein surface mimetics in an array format

Hewitt, S. H., & Wilson, A. J. (2017) · Chemical Communications · doi:10.1039/c7cc06175g · Cited by 17

Lab-on-a-chip electrical multiplexing techniques for cellular and molecular biomarker detection

Liu, F., Ni, L., & Zhe, J. (2018) · Biomicrofluidics · doi:10.1063/1.5022168 · Cited by 17

HOTMAQ: A Multiplexed Absolute Quantification Method for Targeted Proteomics

Zhong, X., Yu, Q., Ma, F., Frost, D. C., Lü, L., Chen, Z., Zetterberg, H., Carlsson, C. M., Okonkwo, O. C., & Li, L. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04580 · Cited by 17

Tryptic digestion of human serum for proteomic mass spectrometry automated by centrifugal microfluidics

Klatt, J.-N., Depke, M., Goswami, N., Paust, N., Zengerle, R., Schmidt, F., & Hutzenlaub, T. (2020) · Lab on a Chip · doi:10.1039/d0lc00530d · Cited by 17

Proteins Modified by the Lipid Peroxidation Aldehyde 9,12-Dioxo-10(E)-dodecenoic Acid in MCF7 Breast Cancer Cells

Slade, P. G., Williams, M. V., Brahmbhatt, V., Dash, A., Wishnok, J. S., & Tannenbaum, S. R. (2010) · Chemical Research in Toxicology · doi:10.1021/tx9002808 · Cited by 17

MALDI‐MS–NIST library approach for colorectal cancer diagnosis

Cristoni, S., Molin, L., Lai, A., Bernardi, L. R., Pucciarelli, S., Agostini, M., Bedin, C., Nitti, D., Seraglia, R., Repetto, O., et al. (2009) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4180 · Cited by 17

HPLC-Chip-Multiple Reaction Monitoring (MRM) method for the label-free absolute quantification of γ-conglutin in lupin: Proteotypic peptides and standard addition method

Resta, D., Brambilla, F., & Arnoldi, A. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2011.08.045 · Cited by 17

Relative Quantification of Biomarkers Using Mixed-Isotope Labeling Coupled With Ms

Chapman, H. M., Schutt, K. L., Dieter, E. M., & Lamos, S. M. (2012) · Bioanalysis · doi:10.4155/bio.12.208 · Cited by 17

Analysis of Secreted Proteins

Severino, V., Farina, A., & Chambery, A. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-360-2_4 · Cited by 17

Advantages and limitations of nanoparticle labeling for early diagnosis of infection

Laurentius, L. B., Owens, N. A., Park, J., Crawford, A. C., & Porter, M. D. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1205489 · Cited by 17

MicroRNAs as Promising Biomarkers for Diagnosing Human Cancer

Huang, Y., Yang, S., Zhang, J., Tan, L., Jiang, F., Li, N., Cheng, J., Lu, Y., & Dai, Y. (2010) · Cancer Investigation · doi:10.3109/07357901003631064 · Cited by 17

Biomarker discovery: tissues versus fluids versus both

Johann, D. J., & Blonder, J. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.5.473 · Cited by 17

A label-free and time-resolved luminescence strategy for the detection of proteins based on DNA–Tb 3+ luminescence quenched by graphene oxide

Li, H., Li, W., Nie, Z., & Yao, S. (2015) · The Analyst · doi:10.1039/c5an01343g · Cited by 16

Current advances in tumor proteomics and candidate biomarkers for hepatic cancer

Peng, X.-Q., Wang, F., Geng, X., & Zhang, W. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.72 · Cited by 16

Synthesis of Surface-Functionalized Molybdenum Disulfide Nanomaterials for Efficient Adsorption and Deep Profiling of the Human Plasma Proteome by Data-Independent Acquisition

Liu, Y., Yang, Q., Du, Z., Liu, J., Zhang, Y., Zhang, W., & Qin, W. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02736 · Cited by 16

Protein Target Quantification Decision Tree

Kim, J. W., & You, J. (2013) · International Journal of Proteomics · doi:10.1155/2013/701247 · Cited by 16

Robust nanoplasmonic substrates for aptamer macroarrays with single-step detection of PDGF-BB

Zhu, D., Yang, R. X., Tang, Y., Li, W., Miao, Z. Y., Hu, Y., Chen, J., Yu, S., Wang, J., & Chen, X. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.05.039 · Cited by 16

Proteomics-Based Identification of Diagnostic Biomarkers Related to Risk Factors and Pathogenesis of Ischemic Stroke

Lee, J., Park, A., Mun, S., Kim, H., Son, H., Choi, H., Kim, D., Lee, S. J., Kim, J. G., & Kang, H. (2020) · Diagnostics · doi:10.3390/diagnostics10050340 · Cited by 16

Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans

Olkowicz, M., Czyżyńska-Cichoń, I., Szupryczyńska, N., Kostogrys, R. B., Kochan, Z., Dȩbski, J., Dadlez, M., Chłopicki, S., & Smolenski, R. T. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02663-8 · Cited by 16

Plasma Proteome Analysis Reveals Overlapping, yet Distinct Mechanisms of Immune Activation in Chronic HCV and HIV Infections

Schlatzer, D., Sugalski, J. M., Chen, Y., Barnholtz‐Sloan, J. S., Davitkov, P., Hazlett, F. E., Funderburg, N., Rodriguez, B. A., Lederman, M. M., Sieg, S. F., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182909847 · Cited by 16

Protein Function Microarrays: Design, Use and Bioinformatic Analysis in Cancer Biomarker Discovery and Quantitation

Duarte, J. D. G., Serufuri, J.-M. S., Mulder, N., & Blackburn, J. M. (2012) · Translational bioinformatics · doi:10.1007/978-94-007-5811-7_3 · Cited by 16

Development of a Malignancy-Associated Proteomic Signature for Diffuse Large B-Cell Lymphoma

Romesser, P. B., Perlman, D. H., Faller, D. V., Costello, C. E., McComb, M. E., & Denis, G. V. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080707 · Cited by 16

Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes

Ramachandran, S., & Kartha, C. S. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-038 · Cited by 16

2D-DIGE as a strategy to identify serum biomarkers in Mexican patients with Type-2 diabetes with different body mass index

Gomez‐Cardona, E., Hernández-Domínguez, E. E., Velarde‐Salcedo, A. J., Pacheco, A.-B., Diaz-Gois, A., León‐Rodríguez, A. D., & de la Rosa, A. P. B. (2017) · Scientific Reports · doi:10.1038/srep46536 · Cited by 16

A selected reaction monitoring mass spectrometric assessment of biomarker candidates diagnosing large-cell neuroendocrine lung carcinoma by the scaling method using endogenous references

Fukuda, T., Nomura, M., Kato, Y., Tojo, H., Fujii, K., Nagao, T., Bando, Y., Fehniger, T. E., Marko‐Varga, G., Nakamura, H., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176219 · Cited by 16

Literature review and methodological considerations for understanding circulating risk biomarkers following trauma exposure

Linnstaedt, S. D., Zannas, A. S., McLean, S. A., Koenen, K. C., & Ressler, K. J. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0636-5 · Cited by 17

Plasmon-Induced Photoreduction System Allows Ultrasensitive Detection of Disease Biomarkers by Silver-Mediated Immunoassay

Xu, D., Sun, Z., Hua, X., Han, H., Ma, W., & Long, Y. (2020) · ACS Sensors · doi:10.1021/acssensors.0c00799 · Cited by 16

Accelerating Protein Biomarker Discovery and Translation From Proteomics Research for Clinical Utility

Chen, J., & Zheng, N. (2020) · Bioanalysis · doi:10.4155/bio-2020-0198 · Cited by 16

The changing scenario in laboratory medicine and the role of laboratory professionals in translational medicine

Plebani, M. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.03.013 · Cited by 16

In Vivo Quantitative Monitoring of Subunit Stoichiometry for Metabolic Complexes

Wilson, R. S., & Thelen, J. J. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00756 · Cited by 15

Advances in aptamer-based nanomaterials for separation and analysis of non-genetic biomarkers in biofluids

Wang, Z., Huang, C., Sun, N., & Deng, C. (2021) · Science China Chemistry · doi:10.1007/s11426-020-9955-y · Cited by 15

Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis

Miyano, T., Mikkaichi, T., Nakamura, K., Yoshigae, Y., Abernathy, K., Ogura, Y., & Kiyosawa, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084291 · Cited by 15

Liquid biopsy for cancer immunotherapy: Biomarkers to predict and monitor response upon immune checkpoint blockade

Son, C. Y., Lee, D., Park, H. S., Choi, J. H., Kim, D. H., Doh, I., Kang, L., Bu, J., Kim, S. M., & Jeon, T. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216767 · Cited by 17

Proteomic Expression Profiling and Identification of Serum Proteins Using Immobilized Trypsin Beads with MALDI-TOF/TOF

Karbassi, I., Nyalwidhe, J. O., Wilkins, C. E., Cazares, L. H., Lance, R. S., Semmes, O. J., & Drake, R. R. (2009) · Journal of Proteome Research · doi:10.1021/pr800836c · Cited by 15

Oil-Encapsulated Nanodroplet Array for Bio-molecular Detection

Qiao, W., Zhang, T., Yen, T., Ku, T., Song, J., Lian, I., & Lo, Y. (2014) · Annals of Biomedical Engineering · doi:10.1007/s10439-014-1039-z · Cited by 15

Analysis of Secreted Proteins as an in vitro Model for Discovery of Liver Toxicity Markers

Lewis, J. A., Dennis, W. E., Hadix, J., & Jackson, D. A. (2010) · Journal of Proteome Research · doi:10.1021/pr1005668 · Cited by 15

In Silico Verification and Parallel Reaction Monitoring Prevalidation of Potential Prostate Cancer Biomarkers

Adeola, H. A., Calder, B., Soares, N. C., Kaestner, L., Blackburn, J. M., & Zerbini, L. F. (2015) · Future Oncology · doi:10.2217/fon.15.296 · Cited by 15

Allosteric kissing complex-based electrochemical biosensor for sensitive, regenerative and versatile detection of proteins

Zhao, M., Zhang, S., Chen, Z., Zhao, C., Wang, L., & Liu, S. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.01.015 · Cited by 15

A systematic simulation-based meta-analytical framework for prediction of physiological biomarkers in alopecia

Muhammad, S. A., Fatima, N., Paracha, R. Z., Ali, A., & Chen, J. Y. (2019) · Journal of Biological Research - Thessaloniki · doi:10.1186/s40709-019-0094-x · Cited by 15

Aggregation of Omic Data and Secretome Prediction Enable the Discovery of Candidate Plasma Biomarkers for Beef Tenderness

Boudon, S., Henry-Berger, J., & Cassar‐Malek, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020664 · Cited by 15

Proteomics to explain and predict meat quality

Gagaoua, M., & Picard, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85879-3.00023-4 · Cited by 15

La protéomique quantitative par la méthode SILAC

Emadali, A., & Gallagher-Gambarelli, M. (2009) · médecine/sciences · doi:10.1051/medsci/20092510835 · Cited by 24

A Novel, High-Sensitivity And Drug-Tolerant Sandwich Immunoassay For The Quantitative Measurement of Circulating Proteins

Sloan, J. H., Ackermann, B. L., Carpenter, J. W., Nguyen, H. T., Stopa, K., Siegel, R. W., & Konrad, R. J. (2012) · Bioanalysis · doi:10.4155/bio.11.312 · Cited by 15

Immunoaffinity Enrichment and Liquid Chromatography-Selected Reaction Monitoring Mass Spectrometry for Quantitation of Carbonic Anhydrase 12 in Cultured Renal Carcinoma Cells

Rafalko, A., Iliopoulos, O., Fusaro, V. A., Hancock, W. S., & Hincapie, M. (2010) · Analytical Chemistry · doi:10.1021/ac101981t · Cited by 15

Liquid chromatography–mass spectrometry: a tool for proteome analysis and biomarker discovery and validation

Ahmed, F. E. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050902832855 · Cited by 15

Synthetic Peptide Arrays for Pathway-Level Protein Monitoring by Liquid Chromatography-Tandem Mass Spectrometry

Hewel, J. A., Liu, J., Onishi, K., Fong, V., Chandran, S., Olsen, J. B., Pogoutse, O., Schutkowski, M., Wenschuh, H., Winkler, D. F. H., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900456-mcp200 · Cited by 15

Aminopeptidase activities as prospective urinary biomarkers for bladder cancer

Taylor, J. M., Yaneva, M., VELASCO, K. R., Philip, J., Erdjument‐Bromage, H., Ostrovnaya, I., Lilja, H. G., Bochner, B. H., & Tempst, P. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300118 · Cited by 15

Novel approaches for the identification of biomarkers of aggressive prostate cancer

Kim, Y., & Kislinger, T. (2013) · Genome Medicine · doi:10.1186/gm460 · Cited by 15

Combined Comparative and Chemical Proteomics on the Mechanisms of levo-Tetrahydropalmatine-Induced Antinociception in the Formalin Test

Wang, C., Zhou, J., Wang, S., Ye, M., Jiang, C., Fan, G., & Zou, H. (2010) · Journal of Proteome Research · doi:10.1021/pr1001274 · Cited by 16

PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis

Carleton, N. M., Zhu, G., Gorbounov, M., Miller, M. C., Pienta, K. J., Resar, L. M. S., & Veltri, R. W. (2018) · The Prostate · doi:10.1002/pros.23499 · Cited by 15

Urinary metabolic signatures reflect cardiovascular risk in the young, middle-aged, and elderly populations

Martínez, P. J., Agudiez, M., Molero, D., Martin‐Lorenzo, M., Martin, M. B., Santiago‐Hernandez, A., García-Segura, J. M., Madruga, F., Cabrera, M., Calvo, E., et al. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01976-x · Cited by 15

Identification of accessible human cancer biomarkers usingex vivochemical proteomic strategies

Kischel, P., Waltregny, D., & Castronovo, V. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.6.727 · Cited by 15

Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?

Rubin, C., Nolin, T. D., & Himmelfarb, J. (2007) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f0b331 · Cited by 15

The Increasing Role of Mass Spectrometry in Quantitative Clinical Proteomics

Whiteaker, J. R. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.150383 · Cited by 15

Proteomic studies of micronutrient deficiency and toxicity

Ali, A., Bhat, B. A., Rather, G. A., Malla, B. A., & Ganie, S. A. (2020) · Plant Micronutrients · doi:10.1007/978-3-030-49856-6_11 · Cited by 15

Mass spectrometry-based proteomics of FFPE tissues: progress, limitations, and clinical translation barriers

AlHammadi, S. A., Nagshabandi, L. N., Muhammad, H., Sukkarieh, H. H., & Aljada, A. (2025) · Clinical Proteomics · doi:10.1186/s12014-025-09567-z · Cited by 15

Biomarker time out

Petzold, A., Bowser, R. P., Calabresi, P., Zetterberg, H., & Uitdehaag, B. M. J. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514524999 · Cited by 14

Quantitative Proteomics Analysis for the Identification of Differential Protein Expression in Calf Muscles between Young and Old SD Rats Using Mass Spectrometry

Kim, J. A., Vetrivel, P., Kim, S. M., Ha, S. E., Kim, H. H., Bhosale, P. B., Heo, J., Lee, W. S., Senthil, K., & Kim, G. S. (2021) · ACS Omega · doi:10.1021/acsomega.0c05821 · Cited by 14

Exploring the Potential of Exosomes as Biomarkers in Tuberculosis and Other Diseases

Arya, R. K., Jit, B. P., Kumar, V., & Kim, J.-J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052885 · Cited by 16

Immunoproteomics: A Review of Techniques, Applications, and Advancements

Gomase, V. S., Dhamane, S. P., & Kakade, P. G. (2024) · Protein and Peptide Letters · doi:10.2174/0109298665333029240926092919 · Cited by 14

Lanthanide Metal–Organic Framework Flowers for Proteome Profiling and Biomarker Identification in Ultratrace Biofluid Samples

Zhang, S., Xu, Z., Chen, Y., Jiang, L., Wang, A., Shen, G., & Ding, X. (2025) · ACS Nano · doi:10.1021/acsnano.4c12280 · Cited by 14

A reproducible approach to high-throughput biological data acquisition and integration

Börnigen, D., Moon, Y. S., Rahnavard, A., Waldron, L., McIver, L. J., Shafquat, A., Franzosa, E. A., Miropolsky, L., Sweeney, C. J., Morgan, X. C., et al. (2015) · PeerJ · doi:10.7717/peerj.791 · Cited by 15

Molecular portraits: the evolution of the concept of transcriptome-based cancer signatures

Modelska, A., Quattrone, A., & Re, A. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv013 · Cited by 15

Proteomic profiling of cerebrospinal fluid in Creutzfeldt–Jakob disease

Qualtieri, A., Urso, E., Pera, M. L., Sprovieri, T., Bossio, S., Gambardella, A., & Quattrone, A. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.80 · Cited by 14

Validation of Candidate Protein Biomarkers

Pavlou, M. P., & Diamandis, E. P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382227-7.00022-7 · Cited by 5

Biomarker discovery and clinical proteomics

Silberring, J., & Ciborowski, P. S. (2009) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2009.11.007 · Cited by 101

Streamlining biomarker discovery

Latterich, M., & Schnitzer, J. E. (2011) · Nature Biotechnology · doi:10.1038/nbt.1917 · Cited by 14

Toward an integrated pipeline for protein biomarker development

Drabovich, A. P., Martínez‐Morillo, E., & Diamandis, E. P. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.09.006 · Cited by 86

Protein Quantitation through Targeted Mass Spectrometry: The Way Out of Biomarker Purgatory?

Carr, S. A., & Anderson, L. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.114686 · Cited by 139